Global Genomics In Cancer Care Market Insights, Forecast to 2029
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genomics In Cancer Care Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Instruments
1.2.3 Consumables
1.2.4 Services
1.3 Market by Application
1.3.1 Global Genomics In Cancer Care Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Diagnostics
1.3.3 Personalized Medicine
1.3.4 Drug Discovery
1.3.5 Development
1.3.6 Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genomics In Cancer Care Market Perspective (2018-2029)
2.2 Global Genomics In Cancer Care Growth Trends by Region
2.2.1 Genomics In Cancer Care Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genomics In Cancer Care Historic Market Size by Region (2018-2023)
2.2.3 Genomics In Cancer Care Forecasted Market Size by Region (2024-2029)
2.3 Genomics In Cancer Care Market Dynamics
2.3.1 Genomics In Cancer Care Industry Trends
2.3.2 Genomics In Cancer Care Market Drivers
2.3.3 Genomics In Cancer Care Market Challenges
2.3.4 Genomics In Cancer Care Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Genomics In Cancer Care by Players
3.1.1 Global Genomics In Cancer Care Revenue by Players (2018-2023)
3.1.2 Global Genomics In Cancer Care Revenue Market Share by Players (2018-2023)
3.2 Global Genomics In Cancer Care Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Genomics In Cancer Care, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Genomics In Cancer Care Market Concentration Ratio
3.4.1 Global Genomics In Cancer Care Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genomics In Cancer Care Revenue in 2022
3.5 Global Key Players of Genomics In Cancer Care Head office and Area Served
3.6 Global Key Players of Genomics In Cancer Care, Product and Application
3.7 Global Key Players of Genomics In Cancer Care, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Genomics In Cancer Care Breakdown Data by Type
4.1 Global Genomics In Cancer Care Historic Market Size by Type (2018-2023)
4.2 Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2029)
5 Genomics In Cancer Care Breakdown Data by Application
5.1 Global Genomics In Cancer Care Historic Market Size by Application (2018-2023)
5.2 Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genomics In Cancer Care Market Size (2018-2029)
6.2 North America Genomics In Cancer Care Market Size by Type
6.2.1 North America Genomics In Cancer Care Market Size by Type (2018-2023)
6.2.2 North America Genomics In Cancer Care Market Size by Type (2024-2029)
6.2.3 North America Genomics In Cancer Care Market Share by Type (2018-2029)
6.3 North America Genomics In Cancer Care Market Size by Application
6.3.1 North America Genomics In Cancer Care Market Size by Application (2018-2023)
6.3.2 North America Genomics In Cancer Care Market Size by Application (2024-2029)
6.3.3 North America Genomics In Cancer Care Market Share by Application (2018-2029)
6.4 North America Genomics In Cancer Care Market Size by Country
6.4.1 North America Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Genomics In Cancer Care Market Size by Country (2018-2023)
6.4.3 North America Genomics In Cancer Care Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Genomics In Cancer Care Market Size (2018-2029)
7.2 Europe Genomics In Cancer Care Market Size by Type
7.2.1 Europe Genomics In Cancer Care Market Size by Type (2018-2023)
7.2.2 Europe Genomics In Cancer Care Market Size by Type (2024-2029)
7.2.3 Europe Genomics In Cancer Care Market Share by Type (2018-2029)
7.3 Europe Genomics In Cancer Care Market Size by Application
7.3.1 Europe Genomics In Cancer Care Market Size by Application (2018-2023)
7.3.2 Europe Genomics In Cancer Care Market Size by Application (2024-2029)
7.3.3 Europe Genomics In Cancer Care Market Share by Application (2018-2029)
7.4 Europe Genomics In Cancer Care Market Size by Country
7.4.1 Europe Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Genomics In Cancer Care Market Size by Country (2018-2023)
7.4.3 Europe Genomics In Cancer Care Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Genomics In Cancer Care Market Size (2018-2029)
8.2 China Genomics In Cancer Care Market Size by Type
8.2.1 China Genomics In Cancer Care Market Size by Type (2018-2023)
8.2.2 China Genomics In Cancer Care Market Size by Type (2024-2029)
8.2.3 China Genomics In Cancer Care Market Share by Type (2018-2029)
8.3 China Genomics In Cancer Care Market Size by Application
8.3.1 China Genomics In Cancer Care Market Size by Application (2018-2023)
8.3.2 China Genomics In Cancer Care Market Size by Application (2024-2029)
8.3.3 China Genomics In Cancer Care Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Genomics In Cancer Care Market Size (2018-2029)
9.2 Asia Genomics In Cancer Care Market Size by Type
9.2.1 Asia Genomics In Cancer Care Market Size by Type (2018-2023)
9.2.2 Asia Genomics In Cancer Care Market Size by Type (2024-2029)
9.2.3 Asia Genomics In Cancer Care Market Share by Type (2018-2029)
9.3 Asia Genomics In Cancer Care Market Size by Application
9.3.1 Asia Genomics In Cancer Care Market Size by Application (2018-2023)
9.3.2 Asia Genomics In Cancer Care Market Size by Application (2024-2029)
9.3.3 Asia Genomics In Cancer Care Market Share by Application (2018-2029)
9.4 Asia Genomics In Cancer Care Market Size by Region
9.4.1 Asia Genomics In Cancer Care Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Genomics In Cancer Care Market Size by Region (2018-2023)
9.4.3 Asia Genomics In Cancer Care Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type
10.2.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application
10.3.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country
10.4.1 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Illumina
11.1.1 Illumina Company Details
11.1.2 Illumina Business Overview
11.1.3 Illumina Genomics In Cancer Care Introduction
11.1.4 Illumina Revenue in Genomics In Cancer Care Business (2018-2023)
11.1.5 Illumina Recent Developments
11.2 Thermo Fisher scientific
11.2.1 Thermo Fisher scientific Company Details
11.2.2 Thermo Fisher scientific Business Overview
11.2.3 Thermo Fisher scientific Genomics In Cancer Care Introduction
11.2.4 Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023)
11.2.5 Thermo Fisher scientific Recent Developments
11.3 Agilent
11.3.1 Agilent Company Details
11.3.2 Agilent Business Overview
11.3.3 Agilent Genomics In Cancer Care Introduction
11.3.4 Agilent Revenue in Genomics In Cancer Care Business (2018-2023)
11.3.5 Agilent Recent Developments
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Genomics In Cancer Care Introduction
11.4.4 Roche Revenue in Genomics In Cancer Care Business (2018-2023)
11.4.5 Roche Recent Developments
11.5 Cancer Genetics
11.5.1 Cancer Genetics Company Details
11.5.2 Cancer Genetics Business Overview
11.5.3 Cancer Genetics Genomics In Cancer Care Introduction
11.5.4 Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023)
11.5.5 Cancer Genetics Recent Developments
11.6 Beckman Coulter
11.6.1 Beckman Coulter Company Details
11.6.2 Beckman Coulter Business Overview
11.6.3 Beckman Coulter Genomics In Cancer Care Introduction
11.6.4 Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023)
11.6.5 Beckman Coulter Recent Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Details
11.7.2 Bio-Rad Business Overview
11.7.3 Bio-Rad Genomics In Cancer Care Introduction
11.7.4 Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023)
11.7.5 Bio-Rad Recent Developments
11.8 Danaher
11.8.1 Danaher Company Details
11.8.2 Danaher Business Overview
11.8.3 Danaher Genomics In Cancer Care Introduction
11.8.4 Danaher Revenue in Genomics In Cancer Care Business (2018-2023)
11.8.5 Danaher Recent Developments
11.9 Sigma Aldrich
11.9.1 Sigma Aldrich Company Details
11.9.2 Sigma Aldrich Business Overview
11.9.3 Sigma Aldrich Genomics In Cancer Care Introduction
11.9.4 Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023)
11.9.5 Sigma Aldrich Recent Developments
11.10 Pacific Biosciences
11.10.1 Pacific Biosciences Company Details
11.10.2 Pacific Biosciences Business Overview
11.10.3 Pacific Biosciences Genomics In Cancer Care Introduction
11.10.4 Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023)
11.10.5 Pacific Biosciences Recent Developments
11.11 Quest Diagnostics
11.11.1 Quest Diagnostics Company Details
11.11.2 Quest Diagnostics Business Overview
11.11.3 Quest Diagnostics Genomics In Cancer Care Introduction
11.11.4 Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023)
11.11.5 Quest Diagnostics Recent Developments
11.12 Luminex
11.12.1 Luminex Company Details
11.12.2 Luminex Business Overview
11.12.3 Luminex Genomics In Cancer Care Introduction
11.12.4 Luminex Revenue in Genomics In Cancer Care Business (2018-2023)
11.12.5 Luminex Recent Developments
11.13 Oxford Gene Technology
11.13.1 Oxford Gene Technology Company Details
11.13.2 Oxford Gene Technology Business Overview
11.13.3 Oxford Gene Technology Genomics In Cancer Care Introduction
11.13.4 Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023)
11.13.5 Oxford Gene Technology Recent Developments
11.14 PerkinElmer
11.14.1 PerkinElmer Company Details
11.14.2 PerkinElmer Business Overview
11.14.3 PerkinElmer Genomics In Cancer Care Introduction
11.14.4 PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023)
11.14.5 PerkinElmer Recent Developments
11.15 Qiagen
11.15.1 Qiagen Company Details
11.15.2 Qiagen Business Overview
11.15.3 Qiagen Genomics In Cancer Care Introduction
11.15.4 Qiagen Revenue in Genomics In Cancer Care Business (2018-2023)
11.15.5 Qiagen Recent Developments
11.16 GE Healthcare
11.16.1 GE Healthcare Company Details
11.16.2 GE Healthcare Business Overview
11.16.3 GE Healthcare Genomics In Cancer Care Introduction
11.16.4 GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023)
11.16.5 GE Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Genomics In Cancer Care Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Instruments
Table 3. Key Players of Consumables
Table 4. Key Players of Services
Table 5. Global Genomics In Cancer Care Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 6. Global Genomics In Cancer Care Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Genomics In Cancer Care Market Share by Region (2018-2023)
Table 9. Global Genomics In Cancer Care Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Genomics In Cancer Care Market Share by Region (2024-2029)
Table 11. Genomics In Cancer Care Market Trends
Table 12. Genomics In Cancer Care Market Drivers
Table 13. Genomics In Cancer Care Market Challenges
Table 14. Genomics In Cancer Care Market Restraints
Table 15. Global Genomics In Cancer Care Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Genomics In Cancer Care Revenue Share by Players (2018-2023)
Table 17. Global Top Genomics In Cancer Care by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Table 18. Global Genomics In Cancer Care Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by Genomics In Cancer Care Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of Genomics In Cancer Care, Headquarters and Area Served
Table 21. Global Key Players of Genomics In Cancer Care, Product and Application
Table 22. Global Key Players of Genomics In Cancer Care, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Genomics In Cancer Care Revenue Market Share by Type (2018-2023)
Table 26. Global Genomics In Cancer Care Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Genomics In Cancer Care Revenue Market Share by Type (2024-2029)
Table 28. Global Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Genomics In Cancer Care Revenue Share by Application (2018-2023)
Table 30. Global Genomics In Cancer Care Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Genomics In Cancer Care Revenue Share by Application (2024-2029)
Table 32. North America Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 34. North America Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 36. North America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. North America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 39. Europe Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 41. Europe Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 43. Europe Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Europe Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 46. China Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 47. China Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 48. China Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 49. China Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 50. Asia Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 52. Asia Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Genomics In Cancer Care Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 55. Asia Genomics In Cancer Care Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia Genomics In Cancer Care Market Size by Region (2024-2029) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Type (2024-2029) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Application (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Genomics In Cancer Care Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 62. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size by Country (2024-2029) & (US$ Million)
Table 64. Illumina Company Details
Table 65. Illumina Business Overview
Table 66. Illumina Genomics In Cancer Care Product
Table 67. Illumina Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 68. Illumina Recent Developments
Table 69. Thermo Fisher scientific Company Details
Table 70. Thermo Fisher scientific Business Overview
Table 71. Thermo Fisher scientific Genomics In Cancer Care Product
Table 72. Thermo Fisher scientific Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 73. Thermo Fisher scientific Recent Developments
Table 74. Agilent Company Details
Table 75. Agilent Business Overview
Table 76. Agilent Genomics In Cancer Care Product
Table 77. Agilent Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 78. Agilent Recent Developments
Table 79. Roche Company Details
Table 80. Roche Business Overview
Table 81. Roche Genomics In Cancer Care Product
Table 82. Roche Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 83. Roche Recent Developments
Table 84. Cancer Genetics Company Details
Table 85. Cancer Genetics Business Overview
Table 86. Cancer Genetics Genomics In Cancer Care Product
Table 87. Cancer Genetics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 88. Cancer Genetics Recent Developments
Table 89. Beckman Coulter Company Details
Table 90. Beckman Coulter Business Overview
Table 91. Beckman Coulter Genomics In Cancer Care Product
Table 92. Beckman Coulter Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 93. Beckman Coulter Recent Developments
Table 94. Bio-Rad Company Details
Table 95. Bio-Rad Business Overview
Table 96. Bio-Rad Genomics In Cancer Care Product
Table 97. Bio-Rad Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 98. Bio-Rad Recent Developments
Table 99. Danaher Company Details
Table 100. Danaher Business Overview
Table 101. Danaher Genomics In Cancer Care Product
Table 102. Danaher Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 103. Danaher Recent Developments
Table 104. Sigma Aldrich Company Details
Table 105. Sigma Aldrich Business Overview
Table 106. Sigma Aldrich Genomics In Cancer Care Product
Table 107. Sigma Aldrich Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 108. Sigma Aldrich Recent Developments
Table 109. Pacific Biosciences Company Details
Table 110. Pacific Biosciences Business Overview
Table 111. Pacific Biosciences Genomics In Cancer Care Product
Table 112. Pacific Biosciences Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 113. Pacific Biosciences Recent Developments
Table 114. Quest Diagnostics Company Details
Table 115. Quest Diagnostics Business Overview
Table 116. Quest Diagnostics Genomics In Cancer Care Product
Table 117. Quest Diagnostics Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 118. Quest Diagnostics Recent Developments
Table 119. Luminex Company Details
Table 120. Luminex Business Overview
Table 121. Luminex Genomics In Cancer Care Product
Table 122. Luminex Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 123. Luminex Recent Developments
Table 124. Oxford Gene Technology Company Details
Table 125. Oxford Gene Technology Business Overview
Table 126. Oxford Gene Technology Genomics In Cancer Care Product
Table 127. Oxford Gene Technology Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 128. Oxford Gene Technology Recent Developments
Table 129. PerkinElmer Company Details
Table 130. PerkinElmer Business Overview
Table 131. PerkinElmer Genomics In Cancer Care Product
Table 132. PerkinElmer Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 133. PerkinElmer Recent Developments
Table 134. Qiagen Company Details
Table 135. Qiagen Business Overview
Table 136. Qiagen Genomics In Cancer Care Product
Table 137. Qiagen Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 138. Qiagen Recent Developments
Table 139. GE Healthcare Company Details
Table 140. GE Healthcare Business Overview
Table 141. GE Healthcare Genomics In Cancer Care Product
Table 142. GE Healthcare Revenue in Genomics In Cancer Care Business (2018-2023) & (US$ Million)
Table 143. GE Healthcare Recent Developments
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Genomics In Cancer Care Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Genomics In Cancer Care Market Share by Type: 2022 VS 2029
Figure 3. Instruments Features
Figure 4. Consumables Features
Figure 5. Services Features
Figure 6. Global Genomics In Cancer Care Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Genomics In Cancer Care Market Share by Application: 2022 VS 2029
Figure 8. Diagnostics Case Studies
Figure 9. Personalized Medicine Case Studies
Figure 10. Drug Discovery Case Studies
Figure 11. Development Case Studies
Figure 12. Research Case Studies
Figure 13. Genomics In Cancer Care Report Years Considered
Figure 14. Global Genomics In Cancer Care Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 15. Global Genomics In Cancer Care Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Genomics In Cancer Care Market Share by Region: 2022 VS 2029
Figure 17. Global Genomics In Cancer Care Market Share by Players in 2022
Figure 18. Global Top Genomics In Cancer Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genomics In Cancer Care as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Genomics In Cancer Care Revenue in 2022
Figure 20. North America Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. North America Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 22. North America Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 23. North America Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 24. United States Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Canada Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Europe Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 27. Europe Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 28. Europe Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 29. Europe Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 30. Germany Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. France Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. U.K. Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Italy Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Russia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Nordic Countries Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. China Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 37. China Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 38. China Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 39. Asia Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 40. Asia Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 41. Asia Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 42. Asia Genomics In Cancer Care Market Share by Region (2018-2029)
Figure 43. Japan Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. South Korea Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. China Taiwan Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Southeast Asia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. India Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Australia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Genomics In Cancer Care Market Size YoY (2018-2029) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Type (2018-2029)
Figure 51. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Application (2018-2029)
Figure 52. Middle East, Africa, and Latin America Genomics In Cancer Care Market Share by Country (2018-2029)
Figure 53. Brazil Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Mexico Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Turkey Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Saudi Arabia Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Israel Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. GCC Countries Genomics In Cancer Care Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Illumina Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 60. Thermo Fisher scientific Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 61. Agilent Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 62. Roche Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 63. Cancer Genetics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 64. Beckman Coulter Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 65. Bio-Rad Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 66. Danaher Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 67. Sigma Aldrich Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 68. Pacific Biosciences Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 69. Quest Diagnostics Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 70. Luminex Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 71. Oxford Gene Technology Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 72. PerkinElmer Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 73. Qiagen Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 74. GE Healthcare Revenue Growth Rate in Genomics In Cancer Care Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed